Numab Therapeutics (private company)

Switzerland
See something wrong or missing? Let us know
Offices:Zurich
Business model:B2B

Numab Therapeutics is an oncology-focused biopharmaceutical company from Switzerland

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 111.5M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Numab Therapeutics

Name Criteria
United Kingdom Achilles Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Ireland SynOx Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Finland Rappta Therapeutics
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Germany Adrenomed AG
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: HBM Healthcare Investments
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Switzerland Pharvaris
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Cormorant Asset Management
  • Total raised in a similar range: 10M+ USD
Germany AMSilk
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Top